Treatment.com AI Inc. (CSE: TRUE) Announces Binding Letter of Intent to Acquire Alea Health Holdings

Highlights

• Treatment.com AI to acquire Alea Health, enhancing AI-driven mental health care capabilities.
• Alea Health’s AI platform optimizes patient engagement and streamlines administrative processes.
• Acquisition strengthens Treatment’s position in the rapidly growing UAE healthcare market.

Treatment.com AI Inc. (CSE: TRUE) is pleased to announce that it has entered into a binding letter of intent (LOI) on January 28, 2025, for the proposed acquisition of Alea Health Holdings Limited (“Alea Health”). This acquisition aligns with Treatment’s strategic vision to expand its AI-powered solutions in healthcare, particularly in the mental health sector. Alea Health, a UAE-based technology company, has developed a cutting-edge online therapy platform that leverages artificial intelligence (AI) to improve mental healthcare delivery through enhanced patient engagement and optimized administrative processes.

Alea Health’s platform uses conversational AI and voice technology to facilitate patient intake and follow-up, significantly reducing the administrative burden on healthcare providers while improving patient satisfaction. This aligns perfectly with Treatment’s mission of utilizing AI to revolutionize healthcare delivery, making it more efficient, accessible, and personalized.

The acquisition of Alea Health will bolster Treatment’s already formidable AI-driven healthcare platform, particularly its Global Library of Medicine (GLM), which powers a personalized AI engine capable of managing over 1,000 diseases and 10,000 symptoms and risk factors. With the addition of Alea Health’s proprietary technology, Treatment will further expand its ability to provide comprehensive, unified healthcare solutions across both primary and mental health care domains.

Treatment has long been a proponent of conversational AI in healthcare and sees immense potential in its ability to streamline processes such as multilingual patient intake, clinical decision support, remote patient monitoring, and post-discharge follow-up. In particular, the mental health space represents a rapidly growing market where AI can play a transformative role. By integrating Alea Health’s innovative platform with Treatment’s GLM, the company aims to offer a more cohesive and advanced solution to healthcare systems globally.

Alea Health’s expertise in mental health is especially significant. Its platform integrates AI-driven analysis, including sentiment analysis and natural language processing of voice data, to optimize therapeutic matching and predict therapeutic alliance, both key factors in achieving positive mental health outcomes. Additionally, Alea Health boasts a network of over 35 internationally licensed therapists and offers a 24/7 AI-powered mental health coach for continuous support between therapy sessions.

This acquisition also provides Treatment with a critical foothold in the UAE and the broader GCC (Gulf Cooperation Council) region, which has committed to investing up to $135 billion by the end of 2024 to revolutionize healthcare through AI and data-driven innovations. With Alea Health’s established presence in the UAE, Treatment can leverage local relationships and tap into a rapidly modernizing healthcare market.

Treatment’s commitment to advancing mental health care through AI-driven solutions will be further reinforced by Alea Health’s approach, which combines AI, therapy, and voice technology to create a truly integrated mental health care experience. As part of this acquisition, Treatment plans to expand its mental health capabilities further throughout 2025, incorporating more advanced AI tools and solutions to improve patient outcomes and healthcare delivery.

Through this strategic acquisition, Treatment.com AI Inc. is set to strengthen its position as a leader in AI-driven healthcare and mental health solutions, driving innovation and improving accessibility and efficiency for healthcare providers and patients alike.